GHDX

Genomic Health, Inc. Press Releases

$31.03
*  
0.07
0.23%
Get GHDX Alerts
*Delayed - data as of Mar. 3, 2015 14:35 ET  -  Find a broker to begin trading GHDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GHDX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Genomic Health Announces Year-End 2014 Financial Results, Provides 2015 Financial Outlook
2/10/2015 4:02:00 PM - PR Newswire


Following NICE's Exclusive Recommendation, NHS England Agrees to Access Program for Oncotype DX® Breast Cancer Test
2/5/2015 7:00:00 AM - PR Newswire


Inivata Limited Announces New Board Member Patrick Terry
2/5/2015 4:00:00 AM - PR Newswire


Genomic Health to Announce Fourth Quarter and Year-End 2014 Financial Results and Host Conference Call on Tuesday, February 10, 2015
2/3/2015 8:00:00 AM - PR Newswire


Genomic Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/5/2015 8:00:00 AM - PR Newswire
▼-2.97 % Price Change since this news event. The Volume Ratio is 6.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Claritas Genomics Appoints Patrick F. Terry as Chief Commercial Officer
12/18/2014 8:00:00 AM - PR Newswire
▼-0.45 % Price Change since this news event. The Volume Ratio is 0.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Oncotype DX® DCIS Score™ Represents Breakthrough in Personalizing Treatment of Pre-Invasive Breast Cancer
12/12/2014 8:30:00 AM - PR Newswire
▼-4.99 % Price Change since this news event. The Volume Ratio is 0.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health Announces Presentation of First Prospective Outcomes Study of Oncotype DX® Breast Cancer Test
12/10/2014 8:00:00 AM - PR Newswire
▼-6.68 % Price Change since this news event. The Volume Ratio is 1.18.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomic Health Advances Development of Novel Liquid Biopsy-Based Cancer Tests
12/9/2014 9:00:00 AM - PR Newswire
▼-4.38 % Price Change since this news event. The Volume Ratio is 1.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day